Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
Amir Ghaemi, Parisa Roshani Asl, Hedieh Zargaran and 5 more
Frontiers in Immunology · 2022
doi:10.3389/fimmu.2022.974364 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.